Cubist Systematic Strategies, LLC Kodiak Sciences Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.1 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.29 - $4.48 $30,555 - $59,776	-13,343 Reduced 11.84%	99,335 $233,000
Q1 2024 May 15, 2024	BUY	$3.01 - $7.45 $242,494 - $600,194	80,563 Added 250.86%	112,678 $592,000
Q4 2023 Feb 14, 2024	BUY	$1.4 - $3.24 $24,911 - $57,652	17,794 Added 124.25%	32,115 $97,000
Q3 2023 Nov 14, 2023	SELL	$1.8 - $7.49 $43,302 - $180,186	-24,057 Reduced 62.68%	14,321 $25,000
Q2 2023 Aug 14, 2023	BUY	$4.3 - $9.48 $104,412 - $230,193	24,282 Added 172.26%	38,378 $264,000
Q1 2023 May 15, 2023	SELL	$4.81 - $8.88 $385,521 - $711,732	-80,150 Reduced 85.04%	14,096 $87,000
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.05 $873,471 - $1.08 Million	-133,968 Reduced 58.7%	94,246 $674,000
Q3 2022 Nov 14, 2022	BUY	$7.57 - $12.5 $133,693 - $220,762	17,661 Added 8.39%	228,214 $1.77 Million
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.48 $1.07 Million - $2.02 Million	-212,862 Reduced 50.27%	210,553 $1.61 Million
Q1 2022 May 16, 2022	BUY	$7.09 - $89.45 $2.9 Million - $36.6 Million	409,506 Added 2944.18%	423,415 $3.27 Million
Q4 2021 Feb 14, 2022	BUY	$80.85 - $128.49 $594,004 - $944,016	7,347 Added 111.96%	13,909 $1.18 Million
Q3 2021 Nov 15, 2021	SELL	$81.97 - $106.94 $382,390 - $498,875	-4,665 Reduced 41.55%	6,562 $630,000
Q2 2021 Aug 16, 2021	BUY	$77.2 - $126.54 $492,304 - $806,945	6,377 Added 131.48%	11,227 $1.04 Million
Q1 2021 May 17, 2021	BUY	$110.45 - $164.47 $185,887 - $276,803	1,683 Added 53.14%	4,850 $550,000
Q4 2020 Feb 16, 2021	SELL	$60.78 - $154.03 $16,532 - $41,896	-272 Reduced 7.91%	3,167 $465,000
Q3 2020 Nov 16, 2020	BUY	$45.05 - $59.27 $154,926 - $203,829	3,439 New	3,439 $204,000
Q1 2020 May 15, 2020	SELL	$38.18 - $73.95 $296,429 - $574,147	-7,764 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.9 - $76.65 $107,919 - $595,110	7,764 New	7,764 $559,000

Others Institutions Holding KOD

# of Institutions

109

Shares Held

40.9M

Call Options Held

28.4K

Put Options Held

21.2K

Baker Bros. Advisors LP New York, NY

17.3M
Shares

$64.4 Million
1.91% of portfolio
Black Rock Inc. New York, NY

3.85M
Shares

$14.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.68M
Shares

$6.26 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.53M
Shares

$5.7 Million
0.04% of portfolio
Price T Rowe Associates Inc Baltimore, MD

1.27M
Shares

$4.72 Million
0.0% of portfolio

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $194M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account